Navigation Links
Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients
Date:9/13/2011

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, Sept. 13 (HealthDay News) -- Searching for cancer in lots of lymph nodes after colon cancer surgery does not seem to increase patients' chances of survival, a new study finds.

Researchers from the U.S. National Cancer Institute analyzed data on more than 86,000 cancer patients from the Surveillance, Epidemiology and End Results (SEER) cancer registry.

The investigators found that over the past 20 years, there's been a trend toward pathologists evaluating more and more lymph nodes in the hunt for cancer cells that have spread beyond the colon, according to the study in the Sept. 14 issue of the Journal of the American Medical Association.

Though there can be variations in treatment, colon cancer patients whose tumors have metastasized, or spread to the lymph nodes, typically receive chemotherapy, while those with localized tumors are often treated with surgery alone, explained study author Helen Parsons, a public health advisor at the U.S. National Cancer Institute.

Presumably, evaluating more lymph nodes would increase the chances of finding cancer cells that have spread and help to get patients the right level of treatment, Parsons said.

During 1988-1990, about 35 percent of the patients studied had 12 lymph nodes or more evaluated. That rose to 47 percent in 2000-2002 and to nearly 74 percent in 2006-2008, according to the report.

And yet, despite evaluating so many more lymph nodes, pathologists didn't identify many more metastatic cancers.

In 1988-1990, about 40 percent of colon cancers were found to have spread to the lymph nodes, rising only slightly to 42 percent in 2006-2008.

"We found that while the number of lymph nodes patients had evaluated increased dramatically over the past 20 years, it hasn't led to significant increases in the overall proportion of lymph node-positive colon cancers identified," Parsons said.

Still, there was an association between the number of lymph nodes evaluated and survival. Patients who had more lymph nodes evaluated had a greater chance of surviving for five years than those with none or just a few nodes evaluated.

For example, patients with no nodes evaluated were 1.2 times more likely to die than those who had one to eight nodes evaluated regardless of whether the nodes were found to be cancerous or not. Patients who had between 12 and 15 nodes evaluated were 17 percent less likely to die than those who only had between one and eight evaluated; patients who had more than 40 nodes evaluated had a 36 percent decreased risk of death.

Put another way, about 55.4 percent of patients with no nodes evaluated died within five years; that dropped to 46.6 percent of those who had 12 to 15 evaluated and 33.3 percent of those who had more than 40 nodes evaluated.

But since there wasn't a strong link between evaluating more nodes and finding more cancers, researchers concluded that other qualities about the doctors or the hospitals may explain the differences in survival rates, rather than the node evaluation itself.

"Patients who had a large number of lymph nodes evaluated were only slightly more likely to be lymph node-positive than those who had only a few lymph nodes evaluated, and yet the group that got more lymph nodes evaluated had significantly lower mortality," Parsons said. "That suggests that something else . . . is the primary mechanism by which we are seeing the relationship."

Lymph node evaluation is one measure that's being used to assess hospital quality, but the study calls into question whether it's a useful measure, Parsons said. The National Quality Forum and several surgical consensus panels all recommend testing 12 or more lymph nodes, Parsons said.

Prior research has shown that if cancer is going to be found in lymph nodes, the chances are it will be found in the first five or so lymph nodes, and then the odds of turning up cancer drop quickly from there, Parsons said.

"We're not saying we shouldn't evaluate lymph nodes. It's still important. But using this as a measure for reimbursement, or a marker for quality may have a limited impact on improving survival," she added.

In an accompanying editorial, Dr. Sandra Wong, an assistant professor of surgery at University of Michigan, said the research is more evidence that evaluating lots and lots of lymph nodes after surgery for colon cancer doesn't seem to help cancer patients much.

Wong was the author of a 2007 study that found hospitals that did a lot of node evaluation didn't have better colon cancer survival rates than hospitals that did less.

"The theory that evaluating lots of nodes can help you find more positive nodes isn't holding up," Wong said.

But this study found an association with greater survival, which suggests a "missing link" to explain it.

That missing link may lie in the details of the surgery or what treatment the patient received after surgery, information the researchers weren't able to consider, she said. It's a question worth answering, Wong added.

"There is so much focus on finding these lymph nodes," she said. "Those are resources we could be using to improve cancer care, such as providing more colonoscopies or making sure people who have a positive node get chemotherapy."

More information

The U.S. National Cancer Institute has more on staging colon cancer.

SOURCES: Helen M. Parsons, M.P.H., public health advisor, National Cancer Institute, Bethesda, Md.; Sandra Wong, M.D., assistant professor, surgery, University of Michigan, Ann Arbor; Sept. 14, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Screening for HPV persistence and cervical cancer risk
2. Troubled Teens Spotted in Routine School Screenings: Study
3. Single flexible sigmoidoscopy screening associated with reduced colorectal cancer
4. Annual cervical cancer screening persists, despite recommended guidelines
5. New prostate cancer screening test shows promise for diagnosis
6. New high-speed 3-D imaging system holds potential for improved cancer screening
7. Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates
8. Study examines screening for pancreatic cancer in high-risk populations
9. Sudden cardiac death in young athletes: Study suggests many ECG screenings are inaccurate
10. Updating family history of cancer associated with need for earlier or more intense cancer screening
11. Changes in family history of cancer can impact screening recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology: